Rezivertinib Mesylate

Tier C — Watch / trade

Beta Pharma Inc

Originator

2024

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：EGFR T790M

Indications (approved)：Non-small cell lung cancer

Regional status

China

Approved

2024-05-15

Japan

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 3 · Total yield 0.583 g (BPI-7711)

BPI-7711—BPI-7711-0011421372-94-2BPI-7711-002108-01-0BPI-7711-003—BPI-7711-004—BPI-7711-005625-36-5API · Rezivertinib Mesylate

Code	CAS No.	Intermediate
BPI-7711	-	-
BPI-7711-001	1421372-94-2 Available	N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
BPI-7711-002	108-01-0	2-(dimethylamino)ethanol
BPI-7711-003	-	N-(4-(2-(dimethylamino)ethoxy)-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
BPI-7711-004	-	4-(2-(dimethylamino)ethoxy)-6-methoxy-N1-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
BPI-7711-005	625-36-5 Available	3-chloropropanoyl chloride

Frequently asked questions

What are the approved indications of Rezivertinib Mesylate?

Approved indications include: Non-small cell lung cancer.

When does the Rezivertinib Mesylate patent expire?

No public expiry year is available for Rezivertinib Mesylate yet; this page updates once verified.

How many synthesis routes are recorded for Rezivertinib Mesylate?

1 synthesis routes are recorded; the shortest is 3 steps with 0.583 g (BPI-7711) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Rezivertinib Mesylate intermediates?

2 intermediate CAS of Rezivertinib Mesylate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Rezivertinib Mesylate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29